| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -16642.9% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 683.7 | n/a |
| Pr/Book | 4.5 |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | n/a | (1.84) | (0.85)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | n/a | (1.19) | (0.55)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | n/a | (1.42) | (0.52)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 0.01 | (1.22) | (31.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-25 | 0.01 | (1.16) | (17.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Posting of Annual Report and Notice of AGM | 24-Jun-2026 | 15:21 | RNS |
| Acquisition and £2.75 million Fundraise | 24-Jun-2026 | 07:00 | RNS |
| Final Results | 23-Jun-2026 | 17:04 | RNS |
| N4 Pharma appoints new CEO, proposes name change | 24-Feb-2026 | ShareCast |
| N4 Pharma reports narrower full-year operating l... | 06-Jun-2025 | ShareCast |
| N4 Pharma files for new UK patent | 04-Dec-2024 | ShareCast |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 0.65p |
| Change Today | -0.025p |
| % Change | -3.70 % |
| 52 Week High | 0.70 |
| 52 Week Low | 0.60 |
| Volume | 5,108,123 |
| Shares Issued | 832.28m |
| Market Cap | £5.41m |
| Value |
|
|---|
| Value |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:18 | 147,058 @ 0.68p |
| 13:51 | 1,000,000 @ 0.70p |
| 14:37 | 37,152 @ 0.60p |
| 14:36 | 113,043 @ 0.60p |
| 13:59 | 25,714 @ 0.70p |
You are here: research